Your browser doesn't support javascript.
loading
APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials.
Evans, Cynthia D; Sparks, JonDavid; Andersen, Scott W; Brooks, Dawn A; Hauck, Paula M; Mintun, Mark A; Sims, John R.
Affiliation
  • Evans CD; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sparks J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Andersen SW; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Brooks DA; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Hauck PM; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Mintun MA; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sims JR; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania, USA.
Alzheimers Dement ; 19(12): 5407-5417, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37204338
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Dement Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Dement Year: 2023 Document type: Article Affiliation country: Country of publication: